Regent Peak Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Regent Peak Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Buy	1,901 +37	+2%	+$4.88K	0.04%	186
2026 Q1	$260K	Buy	1,864 +133	+8%	+$18.6K	0.05%	159
2025 Q4	$212K	Buy	+1,731	New	+$210K	0.04%	178
2023 Q1	–	Sell	-2,662	Closed	-$229K	–	167
2022 Q4	$229K	Buy	+2,662	New	+$211K	0.07%	144
2021 Q1	–	Sell	-1,009	Closed	-$59K	–	471
2020 Q4	$59K	Buy	+1,009	New	+$60.9K	0.02%	284
2020 Q2	–	Sell	-4,749	Closed	-$355K	–	122
2020 Q1	$355K	Buy	+4,749	New	+$328K	0.2%	76

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Regent Peak Wealth Advisors's GILD Position: Q2 2026 in Review

Regent Peak Wealth Advisors increased its Gilead Sciences (GILD) stake by 2% in Q2 2026, buying an estimated $4.88K and bringing the position to 1,901 shares worth $240K. The position accounts for 0.04% of the portfolio, ranked #186.

Regent Peak Wealth Advisors first reported a position in GILD in Q1 2020 and has held it in 6 quarters since. The position peaked at $355K in Q1 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Regent Peak Wealth Advisors held 1,901 shares of Gilead Sciences worth $240K as of Q2 2026.
Regent Peak Wealth Advisors bought 37 Gilead Sciences shares in Q2 2026, an estimated $4.88K.
Gilead Sciences made up 0.04% of Regent Peak Wealth Advisors's portfolio in Q2 2026, its #186 holding.
Regent Peak Wealth Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 6 quarters since.
Regent Peak Wealth Advisors's Gilead Sciences position peaked at $355K in Q1 2020.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Regent Peak Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.